r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

GP

Gary W. Pace

Insider · Director · CRDF

Gary W. Pace files insider transactions with the SEC as a director of Cardiff Oncology (CRDF). We hold 2 disclosed purchases and sales filed since 8 March 2006, 2 of them in the last 90 days.

  • Files forCRDF
  • Disclosed buys and sells2 in all, 2 in the last 90 days
  • Last disclosure16 July 2026

Positions held

7 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 11 May 2020 — 14 July 2026Director · Cardiff Oncology (CRDF)27 Form 4 lines · source: SEC Form 4
  • Filed 2 June 2011 — 8 March 2024Director · Pacira Pharmaceuticals (PCRX)59 Form 4 lines · source: SEC Form 4
  • Filed 16 April 2020 — 16 April 2020Director · Trovagene (TROV)1 Form 4 line · source: SEC Form 4
  • Filed 7 March 2006 — 8 May 2018Director · Resmed (RMD)71 Form 4 lines · source: SEC Form 4
  • Filed 4 December 2008 — 19 February 2010Director · Celsion (CLSN)5 Form 4 lines · source: SEC Form 4
  • Filed 28 November 2008 — 3 December 2008Director · Peplin (PLI)10 Form 4 lines · source: SEC Form 4
  • Filed 15 March 2006 — 15 March 2008Director · Celsion (CLN)7 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.